The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(4-benzylpiperidin-1-yl)(5-methyl-2-(pyridin-4-yl)phenyl)-methanone ID: ALA5288993
Max Phase: Preclinical
Molecular Formula: C25H26N2O
Molecular Weight: 370.50
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1ccc(-c2ccncc2)c(C(=O)N2CCC(Cc3ccccc3)CC2)c1
Standard InChI: InChI=1S/C25H26N2O/c1-19-7-8-23(22-9-13-26-14-10-22)24(17-19)25(28)27-15-11-21(12-16-27)18-20-5-3-2-4-6-20/h2-10,13-14,17,21H,11-12,15-16,18H2,1H3
Standard InChI Key: FCJWBZFNRDSZHR-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
6.3767 -2.4434 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3755 -3.2684 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0883 -3.6800 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8026 -3.2679 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7998 -2.4398 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0865 -2.0319 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0899 -4.5004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3758 -4.9109 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3753 -5.7327 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0881 -6.1450 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.8030 -5.7295 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8000 -4.9090 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0840 -1.2093 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6629 -3.6791 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6622 -4.5016 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.9508 -3.2673 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.9509 -2.4405 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2429 -2.0287 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5278 -2.4359 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5252 -3.2594 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2376 -3.6757 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8173 -2.0213 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1031 -2.4294 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3931 -2.0169 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6794 -2.4243 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6751 -3.2477 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3906 -3.6621 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1015 -3.2524 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 7 1 0
3 7 1 0
6 13 1 0
2 14 1 0
14 15 2 0
14 16 1 0
16 17 1 0
16 21 1 0
17 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
19 22 1 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 27 1 0
27 28 2 0
28 23 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 370.50Molecular Weight (Monoisotopic): 370.2045AlogP: 5.15#Rotatable Bonds: 4Polar Surface Area: 33.20Molecular Species: NEUTRALHBA: 2HBD: ┄#RO5 Violations: 1HBA (Lipinski): 3HBD (Lipinski): ┄#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 4.73CX LogP: 4.93CX LogD: 4.93Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.64Np Likeness Score: -0.88
References 1. Koike T, Yoshikawa M, Ando HK, Farnaby W, Nishi T, Watanabe E, Yano J, Miyamoto M, Kondo S, Ishii T, Kuroita T.. (2021) Discovery of Soticlestat, a Potent and Selective Inhibitor for Cholesterol 24-Hydroxylase (CH24H)., 64 (16.0): [PMID:34387987 ] [10.1021/acs.jmedchem.1c00864 ]